Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Giles

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
The American Journal of Geriatric Cardiology|November 13, 2004
Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implicationsPradeep Agarwal, Gary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Hypertension: definitions and guidelinesJohn B Kostis, Franz Messerli, Thomas D Giles
Preventive Cardiology|October 6, 2007
Where are we going? Beyond JNC 7Thomas D Giles, Suzanne Oparil, Thomas G Pickering
The American Journal of Geriatric Cardiology|May 3, 2002
Noncardiac drugs and QTc interval prolongation: an often unrecognized risk factor for adverse cardiovascular outcomesGary E Sander, Gregory S Guillory, Thomas D Giles
Journal of the American Society of Hypertension : JASH|April 23, 2010
An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertensionThomas D Giles, Suzanne Oparil, Antonia Wang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysisThomas D Giles, Thomas Alessi, Das Purkayastha, et al.
Journal of the American College of Cardiology|January 29, 2008
Beta-blocker therapy in hypertension: a need to pause and reflectThomas D Giles, George L Bakris, Michael A Weber
Journal of Cardiovascular Pharmacology|June 17, 2009
Evolving mechanisms of action of beta blockers: focus on nebivololR Preston Mason, Thomas D Giles, James R Sowers
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2006
Prehypertension--what is it and should it be treated?Marvin Moser, Thomas D Giles, Joseph L Izzo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 10, 2006
The ASCOT Trial--are beta-blockers still useful as antihypertensive medication?Marvin Moser, Thomas D Giles, Thomas G Pickering, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
The American Journal of Geriatric Cardiology|November 13, 2004
Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implicationsPradeep Agarwal, Gary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Hypertension: definitions and guidelinesJohn B Kostis, Franz Messerli, Thomas D Giles
Preventive Cardiology|October 6, 2007
Where are we going? Beyond JNC 7Thomas D Giles, Suzanne Oparil, Thomas G Pickering
The American Journal of Geriatric Cardiology|May 3, 2002
Noncardiac drugs and QTc interval prolongation: an often unrecognized risk factor for adverse cardiovascular outcomesGary E Sander, Gregory S Guillory, Thomas D Giles
Journal of the American Society of Hypertension : JASH|April 23, 2010
An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertensionThomas D Giles, Suzanne Oparil, Antonia Wang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysisThomas D Giles, Thomas Alessi, Das Purkayastha, et al.
Journal of the American College of Cardiology|January 29, 2008
Beta-blocker therapy in hypertension: a need to pause and reflectThomas D Giles, George L Bakris, Michael A Weber
Journal of Cardiovascular Pharmacology|June 17, 2009
Evolving mechanisms of action of beta blockers: focus on nebivololR Preston Mason, Thomas D Giles, James R Sowers
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2006
Prehypertension--what is it and should it be treated?Marvin Moser, Thomas D Giles, Joseph L Izzo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 10, 2006
The ASCOT Trial--are beta-blockers still useful as antihypertensive medication?Marvin Moser, Thomas D Giles, Thomas G Pickering, et al.
Pageof 15